10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2021 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2021 10-K (Filed: Feb 16, 2022) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
| Cash flows from operating activities: | |||
| Net income | $ 5,893 | 7,264 | 7,842 |
| Depreciation, amortization and other | 3,398 | 3,601 | 2,206 |
| Stock-based compensation expense | 341 | 330 | 308 |
| Deferred income taxes | (453) | (287) | (289) |
| Acquired in-process research and development | 1,505 | 0 | 0 |
| Other items, net | (229) | (195) | (186) |
| Changes in operating assets and liabilities, net of acquisitions: | |||
| Trade receivables, net | (429) | (427) | (504) |
| Inventories | (165) | (215) | (66) |
| Other assets | (237) | 129 | 10 |
| Accounts payable | (69) | 45 | 164 |
| Accrued income taxes, net | (854) | (249) | (585) |
| Long-term tax liabilities | 204 | (482) | (146) |
| Other liabilities | 356 | 983 | 396 |
| Net cash provided by operating activities | 9,261 | 10,497 | 9,150 |
| Cash flows from investing activities: | |||
| Purchases of marketable securities | (8,900) | (8,477) | (9,394) |
| Proceeds from sales of marketable securities | 4,403 | 2,597 | 8,842 |
| Proceeds from maturities of marketable securities | 8,831 | 4,381 | 20,548 |
| Purchases of property, plant and equipment | (880) | (608) | (618) |
| Cash paid for acquisitions, net of cash acquired | (2,529) | 0 | (13,617) |
| Purchases of equity method investments | (157) | (3,219) | (24) |
| Other | (35) | (75) | (28) |
| Net cash provided by (used in) investing activities | 733 | (5,401) | 5,709 |
| Cash flows from financing activities: | |||
| Net proceeds from issuance of debt | 4,945 | 8,914 | 0 |
| Repayment of debt | (4,150) | (6,450) | (4,514) |
| Repurchases of common stock | (4,975) | (3,486) | (7,702) |
| Dividends paid | (4,013) | (3,755) | (3,509) |
| Other | (78) | (90) | (42) |
| Net cash used in financing activities | (8,271) | (4,867) | (15,767) |
| Increase (decrease) in cash and cash equivalents | 1,723 | 229 | (908) |
| Cash and cash equivalents at beginning of year | 6,266 | 6,037 | |
| Cash and cash equivalents at end of year | 7,989 | 6,266 | 6,037 |
| External Links | |
| AMGEN INC (AMGN) Fiscal Year 2021 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |